Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Transcode Therapeutics Inc
(NQ:
RNAZ
)
0.4993
-0.0047 (-0.93%)
Streaming Delayed Price
Updated: 9:40 AM EDT, Oct 31, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
41,630
Open
0.4917
Bid (Size)
0.4907 (6)
Ask (Size)
0.4994 (5)
Prev. Close
0.5040
Today's Range
0.4917 - 0.5000
52wk Range
0.2160 - 19.42
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
TransCode Therapeutics Announces Safety Review Committee Approval of Second Cohort Opening in Phase 1 TTX-MC138 Clinical Trial Following Favorable Review of Cohort 1 Safety Data
October 23, 2024
From
TransCode Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Intraday Session
October 10, 2024
Via
Benzinga
Performance
YTD
-92.27%
-92.27%
1 Month
-12.56%
-12.56%
3 Month
+78.32%
+78.32%
6 Month
-20.72%
-20.72%
1 Year
-96.63%
-96.63%
More News
Read More
TransCode Therapeutics Completes Initial Dosing of First Cohort in Phase 1 Clinical Trial with TTX-MC138, a microRNA-Targeted Technology
October 10, 2024
From
TransCode Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
October 08, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 08, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
October 08, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
October 03, 2024
Via
Benzinga
TransCode Therapeutics Announces First Patients Treated in Phase 1 Clinical Trial with First-in-Class Lead Therapeutic Candidate
September 17, 2024
From
TransCode Therapeutics, Inc.
Via
GlobeNewswire
TransCode Therapeutics Announces Publication of Study with Lead Therapeutic Candidate Revealing Mechanisms Behind Candidate’s Preclinical Efficacy Against Metastatic Cancer
September 10, 2024
From
TransCode Therapeutics, Inc.
Via
GlobeNewswire
TransCode Therapeutics Awarded $2 Million NIH Grant to Support Clinical Evaluation of Lead Candidate
September 05, 2024
From
TransCode Therapeutics, Inc.
Via
GlobeNewswire
RNAZ Stock Earnings: TransCode Therapeutics Misses EPS for Q2 2024
August 15, 2024
Via
InvestorPlace
TransCode Therapeutics Announces Phase 1 Clinical Trial Initiation
August 15, 2024
From
TransCode Therapeutics, Inc.
Via
GlobeNewswire
Why Pitney Bowes Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket
July 29, 2024
Via
Benzinga
TransCode Therapeutics, Inc. Announces Closing of Public Offering
July 24, 2024
From
TransCode Therapeutics, Inc.
Via
GlobeNewswire
Gold Moves Higher; Coca-Cola Increases FY24 Forecast
July 23, 2024
Via
Benzinga
Why Transcode Therapeutics (RNAZ) Stock Is Down 60%
July 23, 2024
Via
Benzinga
Why Comcast Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
July 23, 2024
Via
Benzinga
Crude Oil Down 2%; GE Aerospace Earnings Top Views
July 23, 2024
Via
Benzinga
Exposures
Fossil Fuels
US Stocks Edge Higher; General Motors Posts Upbeat Earnings
July 23, 2024
Via
Benzinga
Why Is Mira Pharmaceuticals (MIRA) Stock Down 27% Today?
July 23, 2024
Via
InvestorPlace
Why Is TransCode Therapeutics (RNAZ) Stock Down 62% Today?
July 23, 2024
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
July 23, 2024
Via
InvestorPlace
Why SAP Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
July 23, 2024
Via
Benzinga
TransCode Therapeutics, Inc. Announces Pricing of Public Offering
July 22, 2024
From
TransCode Therapeutics, Inc.
Via
GlobeNewswire
TransCode Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
July 22, 2024
From
TransCode Therapeutics, Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.